| Literature DB >> 29636983 |
Lisa T Hoglund1, Laura Pontiggia2, John D Kelly3.
Abstract
BACKGROUND: Patellofemoral joint (PFJ) osteoarthritis (OA) is prevalent in middle-aged and older adults. Despite this, there are minimal studies which have examined conservative interventions for PFJ OA. Weakness of proximal lower extremity muscles is associated with PFJ OA. It is unknown if a hip muscle strengthening and lumbopelvic-hip core stabilization program will improve symptoms and function in persons with PFJ OA. This study examined the feasibility and impact of a 6-week hip muscle strengthening and core stabilization program on pain, symptoms, physical performance, peak muscle torques, and quality of life in persons with PFJ OA.Entities:
Keywords: Exercise; Knee osteoarthritis; Patellofemoral joint; Patellofemoral osteoarthritis; Treatment
Year: 2018 PMID: 29636983 PMCID: PMC5889597 DOI: 10.1186/s40814-018-0262-z
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Fig. 1Peak isometric muscle torque testing positions. a–d The positions of participants during testing. a Hip abductor test position. b Hip extensor test position. c Hip external rotator test position. d Knee extensor test position
Demographic characteristics of participants (n = 20, 100% female)
| PFJ OA group | Control group | ||
|---|---|---|---|
| Age (years) | 50 (46, 56) | 52 (49, 56) | 0.6415 |
| Height (m) | 1.64 (1.60, 1.69) | 1.67 (1.58, 1.73) | 0.8677 |
| Weight (kg) | 102.35 (75.70, 112.30) | 66.55 (60.80, 70.70) |
|
| BMI | 33.04 (28.28, 41.02) | 23.41 (22.51, 27.09) |
|
| History of patellar subluxation or dislocation ( | 1 (dislocation) | 0 | – |
Data are expressed as median (IQR). Values in italics indicate significant differences at the 0.05 significance level in the exploratory analyses (Wilcoxon Rank Sum test)
n number, PFJ OA patellofemoral joint osteoarthritis, BMI body mass index, IQR interquartile range
Diagnostic imaging characteristics for patellofemoral joint osteoarthritis group participants, frequency (n = 10, 100% female)
| Patellofemoral joint | |||||
| OARSI grade | 0 | 1 | 2 | 3 | |
| JSN | Medial | 5 | 2 | 2 | 0 |
| Lateral | 5 | 4 | 0 | 0 | |
| Marginal osteophytes | Medial | 3 | 3 | 0 | 0 |
| Lateral | 2 | 3 | 1 | 0 | |
| Superior | 3 | 6 | 1 | 0 | |
| Inferior | 6 | 4 | 0 | 0 | |
| Subchondral bony sclerosis | Medial | 3 | 2 | 0 | 0 |
| Lateral | 2 | 2 | 1 | 0 | |
| Subluxation | Medial | 6 | 0 | 0 | 0 |
| Lateral | 4 | 2 | 0 | 0 | |
| Tibiofemoral joint | |||||
| OARSI grade | 0 | 1 | 2 | 3 | |
| JSN | Medial | 6 | 2 | 1 | 0 |
| Lateral | 6 | 3 | 0 | 0 | |
| Marginal osteophytes | Medial | 8 | 0 | 1 | 0 |
| Lateral | 8 | 1 | 0 | 0 | |
| Subchondral bony sclerosis | Medial | 4 | 5 | 0 | 0 |
| Lateral | 8 | 1 | 0 | 0 | |
| None | Varus | Valgus | |||
| Tibiofemoral malalignment | 6 | 2 | 1 | – | |
Total may not equal total number participants due to missing data/radiographic views for some participants
n number, OARSI Osteoarthritis Research Society International (0 = none, 1 = mild, 2 = moderate, 3 = severe), JSN joint space narrowing
Baseline test results, comparison between groups
| PFJ OA group | Control group | ||
|---|---|---|---|
| KOOS Pain (0–100) | 63.89 (47.22, 66.67) | 100 (100, 100) |
|
| KOOS Symptom (0–100) | 60.71 (53.57, 67.86) | 98.21 (92.86, 100) |
|
| KOOS ADL (0–100) | 68.38 (47.06, 76.47) | 100 (100, 100) |
|
| KOOS Sport/Rec (0–100) | 30 (20, 50) | 100 (100, 100) |
|
| KOOS QOL (0–100) | 37.50 (25, 43.75) | 100 (100, 100) |
|
| NPRS (0–10) | 3 (3, 6) | 0 (0, 0) |
|
| Hip Ext Rot Torque | 0.15 ± 0.02 | 0.24 ± 0.07 |
|
| Hip Abd Torque | 0.33 (0.31, 0.41) | 0.48 (0.43, 0.59) |
|
| Hip Ext Torque | 0.11 (0.07, 0.21) | 0.27 (0.20, 0.43) |
|
| Knee Ext Torque | 0.43 (0.37, 0.62) | 0.77 (0.72, 0.87) |
|
| TUG (s) | 7.42 (6.46, 8.55) | 5.88 (5.09, 5.96) |
|
| Pre-TUG Pain (0–10) | 2.00 (0.00, 4.00) | 0 (0, 0) |
|
| Post-TUG Pain (0–10) | 2.00 (1.00, 4.00) | 0 (0, 0) |
|
Data are expressed as median (IQR) except for Hip Ext Rot Torque, which is expressed as mean ± SD. Values in italics indicate significant differences at the 0.05 significance level in the exploratory analyses (Wilcoxon Rank Sum test [median {IQR} results] or two-sample t test [mean ± SD] results). KOOS scored from 0 to 100, 100 = best status. NPRS scored from 0 to 10, 10 = worst pain
PFJ OA patellofemoral joint osteoarthritis, KOOS Knee Injury and Osteoarthritis Outcome Score, ADL activity of daily living, Rec recreation, QOL quality of life, NPRS numeric pain rating scale, Ext Rot external rotator, Abd abductor, Ext extensor, TUG Timed-Up-and-Go, IQR interquartile range, SD standard deviation
PFJ OA participant pain rating and KOOS scores: baseline, 6-week follow-up, and change (n = 10)
| Baseline | 6-week follow-up | Participant score change from baseline | ||
|---|---|---|---|---|
| NPRS (0–10) | 3 (3, 6) | 1 (0, 3) | − 2.50 (− 3, − 2) |
|
| KOOS Pain (0–100) | 63.89 (47.22, 66.67) | 77.78 (69.44, 86.11) | 16.67 (5.56, 25.00) |
|
| KOOS Symptom (0–100) | 60.71 (53.57, 67.86) | 75.00 (57.14, 89.29) | 14.29 (10.71, 17.86) |
|
| KOOS ADL (0–100) | 68.38 (47.06, 76.47) | 83.82 (79.41, 94.12) | 15.44 (14.71, 17.65) |
|
| KOOS Sport/Rec (0–100) | 30 (20, 50) | 57.50 (50.00, 75.00) | 25.00 (0, 45.00) |
|
| KOOS QOL (0–100) | 37.50 (25, 43.75) | 50.00 (31.25, 62.50) | 15.63 (6.25, 25.00) |
|
Data are expressed as median (IQR). Values in italics indicate significant change at the 0.05 significance level in the exploratory analyses (Wilcoxon Signed Rank test). KOOS scored from 0 to 100, 100 = best status. NPRS scored from 0 to 10, 10 = worst pain
PFJ OA patellofemoral joint osteoarthritis, n number, NPRS numeric pain rating scale, KOOS Knee Injury and Osteoarthritis Outcome Score, ADL activity of daily living, Rec recreation, QOL quality of life, IQR interquartile range
PFJ OA participant peak isometric muscle torque and TUG at baseline and 6-week follow-up
| Baseline | 6-week follow-up | Change from baseline | ||
|---|---|---|---|---|
| Hip Ext Rot Torque | 0.16 (0.13, 0.16) | 0.19 (0.17, 0.24) | 0.04 (0.02, 0.08) |
|
| Hip Abd Torque | 0.33 (0.31, 0.41) | 0.34 (0.28, 0.46) | − 0.04 (− 0.11, 0.07) | 0.6953 |
| Hip Ext Torque | 0.11 (0.07, 0.21) | 0.16 (0.12, 0.38) | 0.06 (−0.01, 0.10) | 0.1309 |
| Knee Ext Torque | 0.43 (0.37, 0.62) | 0.68 (0.37, 0.75) | 0.06 (−0.03, 0.24) | 0.3223 |
| TUG (s) | 7.61 ± 1.70 | 6.63 ± 1.36 | − 0.98 ± 0.84 |
|
| Pre-TUG Pain (0–10) | 2.00 (0.00, 4.00) | 0 (0, 3) | − 1 (−3, 0) | 0.1719 |
| Post-TUG Pain (0–10) | 2.00 (1.00, 4.00) | 0 (0, 3) | − 2 (−3, 0) | 0.1250 |
Data are expressed as median (IQR) except for TUG which is expressed as mean ± SD. Values in italics indicate significant change at the 0.05 significance level in the exploratory analyses (Wilcoxon Signed Rank test [median {IQR} results] or paired t test [mean ± SD] results)
PFJ OA patellofemoral joint osteoarthritis, Ext Rot external rotator, Abd abductor, Ext extensor, TUG Timed-Up-and-Go, IQR interquartile range, SD standard deviation